People · Operator

Francois R. Michelon

Named in public records as an officer, director or promoter · active 2018–2019 · Biotechnology

1
Companies
3
Filings
$26.8M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
ENDRA Life Sciences Inc.BiotechnologySeries A$26.8M$40.9M2018
Operator network

Francois R. Michelon at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

ALEXANDER TOKMAN · 4 companies · 1 sharedALEXANDER TOKMANRichard Jacroux · 4 companies · 1 sharedRichard JacrouxDavid R. Wells · 3 companies · 1 sharedDavid R. WellsLouis J. Basenese · 2 companies · 1 sharedLouis J. BaseneseMichael Thornton · 2 companies · 1 sharedMichael ThorntonAlexander S. Tokman · 1 companies · 1 sharedAlexander S. Tokm…Alexander Y. Tokman · 1 companies · 1 sharedAlexander Y. Tokm…Anthony J. DiGiandomenico · 1 companies · 1 sharedAnthony J. DiGian…Anthony R. DiGiandomenico · 1 companies · 1 sharedAnthony R. DiGian…Michael J. Harsh · 1 companies · 1 sharedMichael J. HarshMichael R. Thornton · 1 companies · 1 sharedMichael R. Thornt…Michael S. Harsh · 1 companies · 1 sharedMichael S. HarshSanjiv S. Gambhir · 1 companies · 1 sharedSanjiv S. GambhirENDRA Life Sciences Inc. · $26.8M raisedENDRA Life Sciences I…Francois R. MichelonFM
Francois R. Michelon Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Francois R. Michelon on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
ALEXANDER TOKMAN14
Richard Jacroux14
David R. Wells13
Louis J. Basenese12
Michael Thornton12
Anthony R. DiGiandomenico11
Sanjiv S. Gambhir11
Michael R. Thornton11
Alexander Y. Tokman11
Anthony J. DiGiandomenico11
Michael J. Harsh11
Alexander S. Tokman11
Michael S. Harsh11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.